H.C. WAINWRIGHT BIOCONNECT 2021 CONFERENCE

January 11-14, 2021
VIRTUAL CONFERENCE

350+

Confirmed Presenting Companies!

Join us for presenting companies, fireside discussions, meetings with H.C. Wainwright investment banking & research teams, and an evening of virtual entertainment.

Conference Information

Scott Gottlieb

SCOTT GOTTLIEB, M.D.
Physician; Former Commissioner Food and Drug Administration (2017-2019); Former Senior Advisor – CMS


January 11
12:00pm – 1:00pm (EST)

Clinical Trials – Considerations in the current environment and its impact on future design and maintenance


January 12
12:00pm – 1:00pm (EST)

FDA Regulation – Diagnostics and devices, potential changes to come


January 13
12:00pm – 1:00pm (EST)

Clinical Trials – The importance of biomarkers and cytogenetic profiling in drug discovery, development and commercialization

Meet with H.C. Wainwright Investment Banking & Research Teams.

Hear the latest news and updates from company presentations and select fireside discussions.

An evening of virtual entertainment. More details coming soon!

Who Should Participate?

Public & private companies

Industry executives

Business development executives

Institutional investors

Private equity firms

Venture capitalists

This communication is for informational purposes only. It is not intended as an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Since H.C. Wainwright & Co., LLC is not a tax advisor, transactions requiring tax consideration should be reviewed carefully with your tax advisor. All market prices, data and other information are not guaranteed as to completeness or accuracy and are subject
to change without notice. H.C. Wainwright & Co., LLC., Member FINRA, SIPC